← Back to Patent Explorer
US5216131A Expired / Lapsed US ⏱️ 0.0 years remaining

Lymphocyte homing receptors

Assignee: Genentech Inc
•
Filing: 1991-10-31
•
Granted: 1993-06-01
•
Expires: 2011-10-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract DNA isolates coding for the lymphocyte homing receptor and methods of obtaining such DNA are provided, together with expression systems for recombinant production of the lymphocyte homing receptor useful in therapeutic or diagnostic compositions.

Inventors

  • 👤 Laurence A. Lasky
  • 👤 Steven D. Rosen
  • 👤 Scott E. Stachel
  • 👤 Mark S. Singer
  • 👤 Ted A. Yednock

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:12
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/705; A; A61; A61K; A61K38/00; C07K2319/00; C07K2319/01; C07K2319/02; C07K2319/32; C07K2319/33; C07K2319/70; C07K2319/705

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 46 words
A human LHR (HuLHR) comprising the carbohydrate binding domain, the epidermal growth factor domain and a complement binding domain of the amino acid sequence shown in FIG. 1 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 2
Dependent Claim 46 words
A human LHR (HuLHR) comprising the carbohydrate binding domain, the epidermal growth factor domain and a complement binding domain of the amino acid sequence shown in FIG. 1 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 3
Dependent Claim 14 words
The LHR of claim 1, wherein the LHR is not associated with native glycosylation.
Claim 4
Dependent Claim 11 words
The LHR of claim 1, wherein the LHR has variant glycosylation.
Claim 5
Dependent Claim 10 words
The LHR of claim 1 in a physiologically acceptable carrier.
Claim 6
Dependent Claim 13 words
The huLHR of claim 1 in which the transmembrane domain has been inactivated.
Claim 7
Dependent Claim 13 words
The huLHR of claim 1 from which the transmembrane domain has been deleted.
Claim 8
Dependent Claim 13 words
The huLHR of claim 6 from which the cytoplasmic domain has been deleted.
Claim 9
Dependent Claim 46 words
A murine LHR (MLHR) comprising the carbohydrate binding domain, the epidermal growth factor domain and a complement binding domain of the amino acid sequence shown in FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 10
Dependent Claim 46 words
A murine LHR (MLHR) comprising the carbohydrate binding domain, the epidermal growth factor domain and a complement binding domain of the amino acid sequence shown in FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 11
Dependent Claim 65 words
A polypeptide encoded by a DNA able to hybridize under stringent conditions to the complement of a DNA sequence encoding the carbohydrate binding domain, the epidermal growth factor domain or a complement binding domain of the LHR amino acid sequence shown in FIG. 1 or FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 12
Dependent Claim 65 words
A polypeptide encoded by a DNA able to hybridize under stringent conditions to the complement of a DNA sequence encoding the carbohydrate binding domain, the epidermal growth factor domain or a complement binding domain of the LHR amino acid sequence shown in FIG. 1 or FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain, and having LHR biological activity.
Claim 13
Dependent Claim 15 words
The LHR of claim 9 which binds to the high endothelial venules of lymphoid tissue.
Claim 14
Dependent Claim 48 words
The polypeptide of claim 9 wherein the stringent conditions are overnight incubation at 42° C. in a solution comprising: 20% formamide, 5XSSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5XDenhard's solution, 10% dextrane sulfate, and 20 μg/ml denatured, sheared salmon sperm DNA.
Claim 15
Dependent Claim 39 words
The polypeptide of claim 9 encoded by a DNA able to hybridize under stringent conditions to the complement of a DNA encoding the carbohydrate binding domain of the LHR amino acid sequence shown in FIG. 1 or FIG. 2.
Claim 16
Dependent Claim 13 words
The polypeptide of claim 9 which is devoid of a functional transmembrane domain.
Claim 17
Dependent Claim 13 words
The polypeptide of claim 9 which is devoid of a functional cytoplasmic domain.
Claim 18
Dependent Claim 24 words
Mature HuLHR having the amino acid sequence shown in FIG. 1 purified to show a single band on SDS-PAGE as visualized by silver stain.
Claim 19
Dependent Claim 24 words
Mature HuLHR having the amino acid sequence shown in FIG. 1 purified to show a single band on SDS-PAGE as visualized by silver stain.
Claim 20
Dependent Claim 24 words
Mature MLHR having the amino acid sequence shown in FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain.
Claim 21
Dependent Claim 24 words
Mature MLHR having the amino acid sequence shown in FIG. 2 purified to show a single band on SDS-PAGE as visualized by silver stain.

References Cited (Backward Citations)

US5002873A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-05-31 1996-11-30 1997-06-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-05-31 2000-11-30 2001-06-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-05-31 2004-11-30 2005-06-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag